ID   HP1B3_RAT               Reviewed;         553 AA.
AC   Q6P747;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   24-JAN-2024, entry version 116.
DE   RecName: Full=Heterochromatin protein 1-binding protein 3;
GN   Name=Hp1bp3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51; THR-85; SER-441; SER-442
RP   AND SER-445, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Component of heterochromatin that maintains heterochromatin
CC       integrity during G1/S progression and regulates the duration of G1
CC       phase to critically influence cell proliferative capacity. May play a
CC       role in hypoxia-induced oncogenesis. {ECO:0000250|UniProtKB:Q5SSJ5}.
CC   -!- SUBUNIT: Interacts (via PxVxL motif) with CBX5.
CC       {ECO:0000250|UniProtKB:Q5SSJ5}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q5SSJ5}.
CC       Chromosome {ECO:0000250|UniProtKB:Q5SSJ5}. Note=localized in nuclei but
CC       not in nucleoli in interphase. Colocalized with chromosomes in mitosis,
CC       with a gradually increased during G1 progression and a maximum level
CC       during late G1 phase (G1/S). {ECO:0000250|UniProtKB:Q5SSJ5}.
CC   -!- DOMAIN: A central region that included the first H15 (linker histone
CC       H1/H5 globular) domain binds at the entry/exit site of the nucleosomal
CC       DNA. {ECO:0000250|UniProtKB:Q5SSJ5}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC061837; AAH61837.1; -; mRNA.
DR   RefSeq; NP_954539.1; NM_199108.1.
DR   AlphaFoldDB; Q6P747; -.
DR   SMR; Q6P747; -.
DR   BioGRID; 260500; 4.
DR   IntAct; Q6P747; 3.
DR   STRING; 10116.ENSRNOP00000019696; -.
DR   iPTMnet; Q6P747; -.
DR   PhosphoSitePlus; Q6P747; -.
DR   PaxDb; 10116-ENSRNOP00000019696; -.
DR   Ensembl; ENSRNOT00000075852.2; ENSRNOP00000067949.2; ENSRNOG00000014445.8.
DR   Ensembl; ENSRNOT00055037910; ENSRNOP00055030951; ENSRNOG00055022057.
DR   Ensembl; ENSRNOT00060055861; ENSRNOP00060046205; ENSRNOG00060032225.
DR   Ensembl; ENSRNOT00065043218; ENSRNOP00065035415; ENSRNOG00065025091.
DR   GeneID; 313647; -.
DR   KEGG; rno:313647; -.
DR   AGR; RGD:735099; -.
DR   CTD; 50809; -.
DR   RGD; 735099; Hp1bp3.
DR   eggNOG; KOG4012; Eukaryota.
DR   GeneTree; ENSGT00940000155314; -.
DR   InParanoid; Q6P747; -.
DR   OrthoDB; 3029985at2759; -.
DR   PhylomeDB; Q6P747; -.
DR   PRO; PR:Q6P747; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   GO; GO:0005694; C:chromosome; ISS:UniProtKB.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0031491; F:nucleosome binding; ISS:UniProtKB.
DR   GO; GO:0030527; F:structural constituent of chromatin; IEA:InterPro.
DR   GO; GO:0071456; P:cellular response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0070828; P:heterochromatin organization; ISS:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0097298; P:regulation of nucleus size; ISS:UniProtKB.
DR   CDD; cd00073; H15; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 3.
DR   InterPro; IPR005819; H1/H5.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR15832:SF1; HETEROCHROMATIN PROTEIN 1-BINDING PROTEIN 3; 1.
DR   PANTHER; PTHR15832; SHC (SRC HOMOLOGY DOMAIN C-TERMINAL) ADAPTOR HOMOLOG; 1.
DR   Pfam; PF00538; Linker_histone; 3.
DR   PRINTS; PR00624; HISTONEH5.
DR   SMART; SM00526; H15; 3.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 3.
DR   PROSITE; PS51504; H15; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; DNA-binding; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
FT   CHAIN           2..553
FT                   /note="Heterochromatin protein 1-binding protein 3"
FT                   /id="PRO_0000339644"
FT   DOMAIN          157..232
FT                   /note="H15 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   DOMAIN          253..328
FT                   /note="H15 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   DOMAIN          335..411
FT                   /note="H15 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   REGION          30..131
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          231..251
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          422..553
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           253..257
FT                   /note="PxVxL motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
FT   COMPBIAS        65..79
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        94..131
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        429..446
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
FT   MOD_RES         51
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         85
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
FT   MOD_RES         155
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
FT   MOD_RES         156
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
FT   MOD_RES         190
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TEA8"
FT   MOD_RES         247
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
FT   MOD_RES         441
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         442
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         445
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        64
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
FT   CROSSLNK        97
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
FT   CROSSLNK        256
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SSJ5"
SQ   SEQUENCE   553 AA;  60807 MW;  1647A55B69ABEFEB CRC64;
     MATDMSQGEL IHPKALPLIV GAQLIHADKL GEKADDSTMP IRRAVNSTRE TPPKSKLAEG
     EEEKPEPDGS SEESISTVEE PENETPPAPS REAEQPKGEP ESGEKEESKS AEETKKEEKD
     QSKEKEKKVK KTIPAWATLS ASQLARAQKQ TPMASSPRPK MDAILTEAIK ACFQKSGASV
     VAIRKYIIHK YPSLDLERRG YLLKQALKRE LNRGVIKQVK GKGASGSFVV VQKSKTPQKS
     KNRKKGSAVD PEPQVKLEDV LPLAFTRLCE PKEASYSLIR KYVSQYYPKL RVDIRPQLLK
     NALQRAVERG QLEQITGKGA SGTFQLKKSG EKPLLGGSLM EYAILSAIAA MNEPKTCSTT
     ALKKYVLENH PGTNSNYQMH LLKKTLQKCE KNGWLEQISG KGFSGTFQLC FPYYPSPGVL
     FPKKVSDGSE DEDEEEDEEE SSEDSEDEEP PPKRSLQKKT PAKPQGKTAS MKQRGAKPAR
     KVPAAQRGKV RPLPKKAPPK AKTPARKGRP APSAVKKPSG STSKKPVANA RKEAKLPGKG
     KSAMKKKSFK TKK
//
